Evaxion A (EVAX) Long-Term Deferred Tax (2020 - 2025)
Evaxion A (EVAX) reported Long-Term Deferred Tax of $23.2 million for Q4 2025, up 13.36% on a YoY basis from $20.4 million in Q4 2024, and up 13.36% quarter-over-quarter from $20.4 million in Q4 2024.
Evaxion A (EVAX) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends
Evaxion A has reported Long-Term Deferred Tax for 6 years, with the latest figure at $23.2 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Deferred Tax rose 13.36% year-over-year to $23.2 million; the trailing twelve-month figure through Dec 2025 stood at $23.2 million (up 13.36% YoY), and the FY2025 full-year result was $23.2 million, up 13.36% from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $23.2 million, up from $20.4 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $23.2 million in Q4 2025, with the low at $133000.0 in Q3 2021.
- Historically, Long-Term Deferred Tax has averaged $9.1 million across 5 years, with a median of $739000.0 in 2022.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax surged 2474.02% — and 2024, when it rose 7.4%.
- Evaxion A's Long-Term Deferred Tax stood at $133000.0 in 2021, then soared by 455.64% to $739000.0 in 2022, then surged by 2474.02% to $19.0 million in 2023, then advanced by 7.4% to $20.4 million in 2024, then climbed by 13.36% to $23.2 million in 2025.
- The last three Long-Term Deferred Tax figures came in at $23.2 million (Q4 2025), $20.4 million (Q4 2024), and $19.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.16 Mn |
| Dec 31, 2024 | 20.43 Mn |
| Dec 31, 2023 | 19.02 Mn |
| Dec 31, 2022 | 739,000.00 |
| Sep 30, 2021 | 133,000.00 |
| Jun 30, 2021 | 252,000.00 |
| Mar 31, 2021 | 179,000.00 |
| Dec 31, 2020 | 262,000.00 |